• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLX4IP 通过 PIAS1 促进 RAP1 的 SUMO 化,通过 NF-κB 和 Notch 信号协调端粒维持。

SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.

机构信息

Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.

出版信息

Sci Signal. 2021 Jun 29;14(689):eabe9613. doi: 10.1126/scisignal.abe9613.

DOI:10.1126/scisignal.abe9613
PMID:34187905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8353884/
Abstract

The maintenance of telomere length supports repetitive cell division and therefore plays a central role in cancer development and progression. Telomeres are extended by either the enzyme telomerase or the alternative lengthening of telomeres (ALT) pathway. Here, we found that the telomere-associated protein SLX4IP dictates telomere proteome composition by recruiting and activating the E3 SUMO ligase PIAS1 to the SLX4 complex. PIAS1 SUMOylated the telomere-binding protein RAP1, which disrupted its interaction with the telomere-binding protein TRF2 and facilitated its nucleocytoplasmic shuttling. In the cytosol, RAP1 bound to IκB kinase (IKK), resulting in activation of the transcription factor NF-κB and its induction of expression, which promoted Notch signaling and the institution of ALT. This axis could be targeted therapeutically in ALT-driven cancers and in tumor cells that develop resistance to antitelomerase therapies. Our results illuminate the mechanisms underlying SLX4IP-dependent telomere plasticity and demonstrate the role of telomere proteins in directly coordinating intracellular signaling and telomere maintenance dynamics.

摘要

端粒长度的维持支持细胞的重复分裂,因此在癌症的发生和发展中起着核心作用。端粒通过端粒酶或端粒的替代性延长(ALT)途径来延长。在这里,我们发现端粒相关蛋白 SLX4IP 通过招募并激活 E3 SUMO 连接酶 PIAS1 到 SLX4 复合物,从而决定端粒蛋白质组的组成。PIAS1 对端粒结合蛋白 RAP1 进行 SUMO 化修饰,破坏了 RAP1 与端粒结合蛋白 TRF2 的相互作用,并促进了其核质穿梭。在细胞质中,RAP1 与 IκB 激酶(IKK)结合,导致转录因子 NF-κB 的激活及其诱导的表达,从而促进了 Notch 信号转导和 ALT 的建立。在 ALT 驱动的癌症和对抗端粒酶治疗产生耐药性的肿瘤细胞中,可以对该轴进行治疗性靶向。我们的研究结果阐明了 SLX4IP 依赖性端粒可塑性的机制,并证明了端粒蛋白在直接协调细胞内信号和端粒维持动力学方面的作用。

相似文献

1
SLX4IP promotes RAP1 SUMOylation by PIAS1 to coordinate telomere maintenance through NF-κB and Notch signaling.SLX4IP 通过 PIAS1 促进 RAP1 的 SUMO 化,通过 NF-κB 和 Notch 信号协调端粒维持。
Sci Signal. 2021 Jun 29;14(689):eabe9613. doi: 10.1126/scisignal.abe9613.
2
RAP1 moonlights to activate NF-κB and Notch in ALT.RAP1通过兼职功能激活端粒延长替代途径(ALT)中的NF-κB和Notch信号通路。
Sci Signal. 2021 Jun 29;14(689):eabj1166. doi: 10.1126/scisignal.abj1166.
3
Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity.丝氨酸/苏氨酸蛋白激酶激活的蛋白激酶 2 磷酸化信号转导和转录激活因子 1 抑制蛋白(PIAS1)可通过增加 PIAS1 转录抑制和 SUMO E3 连接酶活性抑制内皮炎症。
Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):321-9. doi: 10.1161/ATVBAHA.112.300619. Epub 2012 Nov 29.
4
SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.SLX4IP 氨基端决定了 ALT 样去势抵抗性前列腺癌细胞系中的端粒定位。
Prostate. 2021 Nov;81(15):1235-1251. doi: 10.1002/pros.24225. Epub 2021 Sep 7.
5
PIAS1-mediated sumoylation promotes STUbL-dependent proteasomal degradation of the human telomeric protein TRF2.PIAS1介导的类泛素化促进人端粒蛋白TRF2的STUbL依赖性蛋白酶体降解。
FEBS Lett. 2015 Oct 24;589(21):3277-86. doi: 10.1016/j.febslet.2015.09.030. Epub 2015 Oct 8.
6
SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.SLX4IP 拮抗 BLM 广泛活性以维持 ALT。
Mol Cell. 2019 Oct 3;76(1):27-43.e11. doi: 10.1016/j.molcel.2019.07.010. Epub 2019 Aug 22.
7
The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.KyoT2对Notch/RBP-J信号通路的转录抑制活性受PIAS1催化的SUMO化修饰调控。
J Mol Biol. 2007 Jun 29;370(1):27-38. doi: 10.1016/j.jmb.2007.04.010. Epub 2007 Apr 12.
8
Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.Necdin促进PIAS1 SUMO E3连接酶的泛素依赖性降解。
PLoS One. 2014 Jun 9;9(6):e99503. doi: 10.1371/journal.pone.0099503. eCollection 2014.
9
SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability.PIAS1 介导的 SUMO3 修饰调节雄激素受体的细胞分布和稳定性。
Cell Commun Signal. 2019 Nov 21;17(1):153. doi: 10.1186/s12964-019-0457-9.
10
SUMO Ligase Protein Inhibitor of Activated STAT1 (PIAS1) Is a Constituent Promyelocytic Leukemia Nuclear Body Protein That Contributes to the Intrinsic Antiviral Immune Response to Herpes Simplex Virus 1.激活的信号转导和转录激活因子1的SUMO连接酶蛋白抑制剂(PIAS1)是一种组成性早幼粒细胞白血病核体蛋白,有助于对单纯疱疹病毒1产生内在抗病毒免疫反应。
J Virol. 2016 Jun 10;90(13):5939-5952. doi: 10.1128/JVI.00426-16. Print 2016 Jul 1.

引用本文的文献

1
Loss of SLX4IP leads to common fragile site instability and compromises DNA interstrand crosslink repair in vivo.SLX4IP的缺失会导致常见脆性位点不稳定,并在体内损害DNA链间交联修复。
J Biol Chem. 2025 Jun;301(6):110244. doi: 10.1016/j.jbc.2025.110244. Epub 2025 May 16.
2
Regulation of the immune microenvironment by SUMO in diabetes mellitus.SUMO对糖尿病免疫微环境的调节作用
Front Immunol. 2025 Feb 26;16:1506500. doi: 10.3389/fimmu.2025.1506500. eCollection 2025.
3
PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response.

本文引用的文献

1
SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant Prostate Cancer through ALT-like Telomeric PML Localization.SLX4IP 通过 ALT 样端粒 PML 定位促进雄激素受体非依赖性去势抵抗性前列腺癌中端粒的维持。
Mol Cancer Res. 2021 Feb;19(2):301-316. doi: 10.1158/1541-7786.MCR-20-0314. Epub 2020 Nov 13.
2
SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness.SLX4IP 和端粒动力学决定乳腺癌转移和治疗反应性。
Life Sci Alliance. 2020 Feb 18;3(4). doi: 10.26508/lsa.201900427. Print 2020 Apr.
3
POT1-TPP1 differentially regulates telomerase via POT1 His266 and as a function of single-stranded telomere DNA length.
PIAS家族基因表达:对预后、免疫调节及化疗反应的影响
Am J Transl Res. 2024 Nov 15;16(11):6346-6364. doi: 10.62347/JRDP4018. eCollection 2024.
4
The Altered Functions of Shelterin Components in ALT Cells.端粒酶相关细胞中庇护体蛋白的功能改变。
Int J Mol Sci. 2023 Nov 27;24(23):16830. doi: 10.3390/ijms242316830.
5
Possible molecular mechanisms underlying the development of atherosclerosis in cancer survivors.癌症幸存者动脉粥样硬化发展背后可能的分子机制。
Front Cardiovasc Med. 2023 Jun 2;10:1186679. doi: 10.3389/fcvm.2023.1186679. eCollection 2023.
6
High-resolution structural-omics of human liver enzymes.人类肝脏酶的高分辨率结构组学。
Cell Rep. 2023 Jun 27;42(6):112609. doi: 10.1016/j.celrep.2023.112609. Epub 2023 Jun 7.
7
Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.利用邻近标记和亲和纯化技术对 DNA 修复支架 SLX4 的综合互作组进行映射。
J Proteome Res. 2023 Jun 2;22(6):1660-1681. doi: 10.1021/acs.jproteome.2c00706. Epub 2023 Apr 18.
8
Amplification and Quantitation of Telomeric Extrachromosomal Circles.端粒染色体外环状结构的扩增与定量分析
Bio Protoc. 2023 Mar 5;13(5):e4627. doi: 10.21769/BioProtoc.4627.
9
Toward structural-omics of the bovine retinal pigment epithelium.朝向牛视网膜色素上皮的结构组学研究。
Cell Rep. 2022 Dec 27;41(13):111876. doi: 10.1016/j.celrep.2022.111876.
10
Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases.癌症相关的 SUMO 调节因子失调:蛋白酶和连接酶。
Int J Mol Sci. 2022 Jul 20;23(14):8012. doi: 10.3390/ijms23148012.
POT1-TPP1 通过 POT1 His266 并作为单链端粒 DNA 长度的功能差异调节端粒酶。
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23527-23533. doi: 10.1073/pnas.1905381116. Epub 2019 Nov 4.
4
SLX4IP Antagonizes Promiscuous BLM Activity during ALT Maintenance.SLX4IP 拮抗 BLM 广泛活性以维持 ALT。
Mol Cell. 2019 Oct 3;76(1):27-43.e11. doi: 10.1016/j.molcel.2019.07.010. Epub 2019 Aug 22.
5
Stem cells, immortality, and the evolution of metastatic properties in breast cancer: telomere maintenance mechanisms and metastatic evolution.干细胞、永生与乳腺癌转移特性的演变:端粒维持机制与转移进化
J Cancer Metastasis Treat. 2019;5. doi: 10.20517/2394-4722.2019.15. Epub 2019 May 6.
6
Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression.自噬抑制通过诱导和稳定 Pfkfb3 表达引发转移性休眠的苏醒。
Nat Commun. 2019 Aug 14;10(1):3668. doi: 10.1038/s41467-019-11640-9.
7
TIN2 Functions with TPP1/POT1 To Stimulate Telomerase Processivity.TIN2 通过与 TPP1/POT1 相互作用来刺激端粒酶的延伸性。
Mol Cell Biol. 2019 Oct 11;39(21). doi: 10.1128/MCB.00593-18. Print 2019 Nov 1.
8
CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing.CHOPCHOP v3:扩展 CRISPR 网络工具包,超越基因组编辑。
Nucleic Acids Res. 2019 Jul 2;47(W1):W171-W174. doi: 10.1093/nar/gkz365.
9
Histone Modifications and the Maintenance of Telomere Integrity.组蛋白修饰与端粒完整性的维持。
Cells. 2019 Feb 25;8(2):199. doi: 10.3390/cells8020199.
10
RAD52 and SLX4 act nonepistatically to ensure telomere stability during alternative telomere lengthening.RAD52 和 SLX4 非协同作用以确保替代性端粒延长过程中端粒的稳定性。
Genes Dev. 2019 Feb 1;33(3-4):221-235. doi: 10.1101/gad.319723.118. Epub 2019 Jan 28.